Gaussian Process CATE Estimation with Population-Level ATE Data

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for estimating conditional average treatment effect (CATE) in healthcare overlook the incorporation of population-level knowledge, leading to inaccurate individual-level treatment effect predictions.

Innovation Solution

A precision health system uses Gaussian processes (GPs) to integrate population-level average treatment effects (ATE) data into CATE estimation, constraining potential outcomes with Bayesian quadrature and kernel mean embedding, enabling uncertainty quantification and personalized treatment decisions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If existing methods for estimating CATE are used, then the estimation process is simple, but the accuracy of individual-level treatment effect predictions deteriorates due to lack of population-level knowledge incorporation

Engineering Contradiction:
Improveaccuracy of CATE estimationVSAvoidcomplexity of estimation procedure
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines population-level ATE data with individual-level observational data into a unified GP-based estimation framework. This merging allows the model to leverage both macro-level trends and micro-level variations, thereby improving CATE estimation accuracy while maintaining a coherent and integrated procedure rather than separate analysis steps.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent incorporates population-level ATE data as prior information before performing individual-level CATE estimation. By pre-integrating population-level knowledge into the GP model's prior distribution, the system prepares constraints and guidance that improve individual predictions without requiring complex post-processing or iterative adjustments during the main estimation phase.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If population-level ATE data is incorporated into CATE estimation, then the accuracy of treatment predictions improves, but the complexity of the estimation procedure increases

Engineering Contradiction:
Improvereliability of treatment effect predictionVSAvoidcomplexity of GP model training
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses Gaussian processes as an intermediary framework that naturally bridges population-level ATE data and individual-level CATE estimation. The GP model acts as a mediator that harmonizes different data levels through its probabilistic structure, allowing information flow from population to individual level without requiring complex custom algorithms or multiple separate modeling steps.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the GP model's prior distribution parameters to incorporate population-level ATE data. By adjusting the mean and covariance parameters of the GP prior based on ATE information, the system integrates population knowledge in a mathematically elegant way that improves reliability while avoiding the need for complex structural changes to the estimation procedure.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20250239373A1Incorporating population-level knowledge into conditional average treatment effect estimation
Publication Date: 2025.07.24 MICROSOFT TECHNOLOGY LICENSING LLC
  • US20250239373A1 patent drawing
  • US20250239373A1 patent drawing
  • US20250239373A1 patent drawing

AI summary

Example solutions incorporate population-level information into an estimation procedure of a conditional average treatment effect (CATE) by: receiving observational data associated with a medical treatment; receiving average treatment effect (ATE) data associated with the medical treatment performed across a population of individuals; training a model using at least the observational data and the ATE data, the model being trained to generate at least a conditional average treatment effect (CATE) estimation for the medical treatment; applying patient data of a first patient as input to the model, thereby generating a CATE estimation indicating how the medical treatment would affect the first patient; and causing treatment to be applied to the first patient based on the CATE estimation.